Adage Capital Partners’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Adage Capital Partners's PALI Position: Q3 2026 in Review
Adage Capital Partners held its Palisade Bio (PALI) position steady in Q3 2026 at 4,500,000 shares worth $6.08M. The position accounts for 0.01% of the portfolio, ranked #820.
Adage Capital Partners first reported a position in PALI in Q4 2025 and has held it in 4 quarters since. The position peaked at $10.6M in Q4 2025. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Adage Capital Partners held 4,500,000 shares of Palisade Bio worth $6.08M as of Q3 2026.
- Adage Capital Partners left its Palisade Bio share count unchanged in Q3 2026.
- Palisade Bio made up 0.01% of Adage Capital Partners's portfolio in Q3 2026, its #820 holding.
- Adage Capital Partners first reported a position in Palisade Bio in Q4 2025 and has held it in 4 quarters since.
- Adage Capital Partners's Palisade Bio position peaked at $10.6M in Q4 2025.
- 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.